Gómez Gómez, AlejandroGarcía González, JavierPeiteado, DianaBorrego Sanz, LaraArriola Villalobos, PedroEsteban Ortega, María del MarMartín López, MaríaVentura Hidalgo, MaríaPérez Blázquez, EugenioPato, EsperanzaDíaz Valle, DavidMuñoz Fernández, SantiagoRodríguez Rodríguez, Luis2021-08-252021-08-252021Gómez-Gómez, A., García-González, J., Peiteado, D., Borrego-Sanz, L., Arriola-Villalobos, P., Esteban-Ortega, M., Martín-López, M., Ventura-Hidalgo, M., Pérez-Blázquez, E., Pato, E., Díaz-Valle, D., Muñoz-Fernández, S., & Rodríguez-Rodríguez, L. (2021). Inflammatory Relapses after Immunosuppressive Drug Discontinuation in Uveitis Patients: A Survival Analysis. Ocular Immunology and Inflammation, 29(2), 376-387. https://doi.org/10.1080/09273948.2019.16814690927-39481744-5078http://hdl.handle.net/11268/10314Purpose: To estimate the incidence rate (IR) and identify risk factors associated to inflammatory relapse after immunosuppressive drug (ISD) discontinuation in noninfectious uveitis patients. Methods: Multicenter longitudinal retrospective study, including patients from four uveitis clinics followed-up until December 2018. Hazard ratios for different variables were estimated using multivariable Cox models. Results: 32 patients (34 episodes of ISD discontinuation) were analyzed (median and maximum follow-up time: 2.4 and 19.2 years, respectively). Fourteen patients presented at least one relapse: anterior (8 patients), intermediate (5) and posterior (8). IR (95% confidence interval) of the first relapse was 14.3 (8.6–23.8) episodes per 100 patient-years (median survival time: 4.8 years). Early use of ISDs, panuveitis, and higher oral corticosteroid dosage at discontinuation were associated with higher hazards of relapse in multivariable analysis. Conclusions: Relapse is a frequent and early event after ISD discontinuation. Identifying relapse risk factors could support the physician’s decision regarding ISD discontinuation.engUveítisInmunosupresoresjournal article10.1080/09273948.2019.1681469restricted accessFarmacologíaInmunologíaOftalmología